Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

SOPHiA GENETICS SA (90B.F)

2.7600
-0.1400
(-4.83%)
As of 8:00:56 AM GMT+2. Market Open.
Loading Chart for 90B.F
  • Previous Close 2.9000
  • Open 2.7600
  • Bid 2.7400 x --
  • Ask 2.8000 x --
  • Day's Range 2.7600 - 2.7600
  • 52 Week Range 2.3600 - 5.0000
  • Volume 116
  • Avg. Volume 240
  • Market Cap (intraday) 184.454M
  • Beta (5Y Monthly) 1.02
  • PE Ratio (TTM) --
  • EPS (TTM) -0.8300
  • Earnings Date May 6, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is based in Rolle, Switzerland.

www.sophiagenetics.com

423

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 90B.F

View More

Performance Overview: 90B.F

Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

90B.F
13.21%
S&P 500 (^GSPC)
5.45%

1-Year Return

90B.F
40.77%
S&P 500 (^GSPC)
10.43%

3-Year Return

90B.F
18.82%
S&P 500 (^GSPC)
34.58%

5-Year Return

90B.F
18.82%
S&P 500 (^GSPC)
90.93%

Compare To: 90B.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 90B.F

View More

Valuation Measures

Annual
As of 4/29/2025
  • Market Cap

    185.13M

  • Enterprise Value

    141.12M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.35

  • Price/Book (mrq)

    2.29

  • Enterprise Value/Revenue

    2.47

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -95.89%

  • Return on Assets (ttm)

    -23.02%

  • Return on Equity (ttm)

    -50.41%

  • Revenue (ttm)

    65.17M

  • Net Income Avi to Common (ttm)

    -62.49M

  • Diluted EPS (ttm)

    -0.8300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    80.23M

  • Total Debt/Equity (mrq)

    31.12%

  • Levered Free Cash Flow (ttm)

    -28.36M

Research Analysis: 90B.F

View More

Company Insights: 90B.F

Research Reports: 90B.F

View More